Search

Check out updates to COVID-19 management guideline!

Our guideline working group has reviewed latest evidence and recommends therapeutic anticoagulation (instead of prophylactic) for mild and moderate COVID-19. This is based on review of latest evidence from 3 international trials, demonstrating marked benefit (net benefit in terms of organ-support free days, irrespective of D-dimer levels). No benefit (and possible harm) for severe COVID-19. Endorsed by MUHC P&T committee!

14 views0 comments

Recent Posts

See All

NEW obstetrics-gynecology guidelines!

Hi all, we're pleased to present the following new ob-gyn guidelines: postpartum endometritis, chorioamnionitis, vulvovaginitis/cervicitis/PID - a joint collaboration between ASP and the MUHC Ob-gyn D

Colchicine and COVID-19 - MEMO from MUHC ASP

Dear colleagues, Many of you have seen recent press releases touting the potential benefit of colchicine in outpatient management of COVID-19 (COLCORONA trial). The Collège des médecins and the Ordre

+1 514-934-1934

1001 Decarie Blvd, Montreal, Quebec H4A 3J1, Canada